Wockhardt reports Q1 net of ₹760 crore

The company had posted a net loss of ₹36.88 crore for April-June 2019-20, Wockhardt said.

August 29, 2020 10:48 pm | Updated 10:48 pm IST - NEW DELHI

Drug firm Wockhardt reported a consolidated net profit of ₹759.8 crore for June quarter mainly on account of exceptional items in connection with the transfer of a business comprising 62 products and Baddi facility to Dr. Reddy’s Laboratories.

The company had posted a net loss of ₹36.88 crore for April-June 2019-20, Wockhardt said.

Total income stood at ₹606.22 crore. It was ₹733.66 crore in the year-ago period.

It said that divestment of business undertaking to Dr. Reddy’s Laboratories was accomplished during the quarter and ₹1,483 crore has been received towards the same.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.